Literature DB >> 27400157

Racial Disparities in the Outcomes of Patients With Stage IV Pancreatic Adenocarcinoma Are Mediated by Chemotherapy Utilization.

Jordan J Atkins1, Mark A Fiala, Andrea Wang-Gillam, Tanya M Wildes.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27400157      PMCID： PMC4941626          DOI： 10.1097/MPA.0000000000000618

Source DB:  PubMed          Journal:  Pancreas        ISSN： 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  9 in total

Review 1.  Pancreatic cancer disparities in African Americans.

Authors:  Shumaila N Khawja; Somala Mohammed; Eric J Silberfein; Benjamin L Musher; William E Fisher; George Van Buren
Journal:  Pancreas       Date:  2015-05       Impact factor: 3.327

2.  Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial.

Authors:  Helmut Oettle; Stefan Post; Peter Neuhaus; Klaus Gellert; Jan Langrehr; Karsten Ridwelski; Harald Schramm; Joerg Fahlke; Carl Zuelke; Christof Burkart; Klaus Gutberlet; Erika Kettner; Harald Schmalenberg; Karin Weigang-Koehler; Wolf-Otto Bechstein; Marco Niedergethmann; Ingo Schmidt-Wolf; Lars Roll; Bernd Doerken; Hanno Riess
Journal:  JAMA       Date:  2007-01-17       Impact factor: 56.272

3.  Racial disparities in treatment for pancreatic cancer and impact on survival: a population-based analysis.

Authors:  Vinamrata Singal; Ashwani K Singal; Yong-Fang Kuo
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-15       Impact factor: 4.553

4.  Changes in survival by ethnicity of patients with cancer between 1992-1996 and 2002-2006: is the discrepancy decreasing?

Authors:  D Pulte; M T Redaniel; H Brenner; M Jeffreys
Journal:  Ann Oncol       Date:  2012-03-06       Impact factor: 32.976

5.  Race does not impact pancreatic cancer treatment and survival in an equal access federal health care system.

Authors:  Sukhyung Lee; Jeffrey L Reha; Ching-Wei D Tzeng; Nader N Massarweh; George J Chang; Stephen P Hetz; Jason B Fleming; Jeffrey E Lee; Matthew H Katz
Journal:  Ann Surg Oncol       Date:  2013-09-04       Impact factor: 5.344

6.  Prognostic factors for survival in pancreatic cancer: a population-based study.

Authors:  Mohamad A Eloubeidi; Renee A Desmond; C Mel Wilcox; Reda J Wilson; Pavan Manchikalapati; Mona M Fouad; Isam Eltoum; Selwyn M Vickers
Journal:  Am J Surg       Date:  2006-09       Impact factor: 2.565

7.  Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: the CONKO-001 randomized trial.

Authors:  Helmut Oettle; Peter Neuhaus; Andreas Hochhaus; Jörg Thomas Hartmann; Klaus Gellert; Karsten Ridwelski; Marco Niedergethmann; Carl Zülke; Jörg Fahlke; Michael B Arning; Marianne Sinn; Axel Hinke; Hanno Riess
Journal:  JAMA       Date:  2013-10-09       Impact factor: 56.272

8.  Disparities in pancreas cancer care.

Authors:  Anasooya Abraham; Waddah B Al-Refaie; Helen M Parsons; Vikas Dudeja; Selwyn M Vickers; Elizabeth B Habermann
Journal:  Ann Surg Oncol       Date:  2013-04-12       Impact factor: 5.344

9.  Survival improvement in patients with pancreatic cancer by decade: a period analysis of the SEER database, 1981-2010.

Authors:  Huanhuan Sun; Haiqing Ma; Guobin Hong; Hongliu Sun; Jin Wang
Journal:  Sci Rep       Date:  2014-10-23       Impact factor: 4.379
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.